Cleared Traditional

K901817 - FUKUDA DENSHI MODEL FX-3101

K901817 is an FDA 510(k) clearance for FUKUDA DENSHI MODEL FX-3101, manufactured by Fukuda Denshi USA, Inc.. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 122-day FDA review.

K901817 · Fukuda Denshi USA, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1990
Decision
122d
Days
Class 2
Risk

K901817 is an FDA 510(k) clearance for the FUKUDA DENSHI MODEL FX-3101. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Fukuda Denshi USA, Inc. (Redmond, US). The FDA issued a Cleared decision on August 23, 1990 after a review of 122 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Fukuda Denshi USA, Inc. devices

FDA 510(k) Submission Details - K901817

510(k) Number K901817 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 1990
Decision Date August 23, 1990
Days to Decision 122 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d faster than avg
Panel avg: 125d · This submission: 122d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 418
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K901817.
HORIZON 2000 ST ANALYSIS OPTION
K903524 · Mennen Medical, Inc. · Mar 1991
MODEL 405
K904606 · Ivy Biomedical Systems, Inc. · Mar 1991
CARDIOFAX ECG-8830A
K904758 · Nihon Kohden America, Inc. · Dec 1990
TRAMSCOPE SYSTEM
K900598 · Marquette Electronics, Inc. · Apr 1990
SMU 611 UNIVERSALMONITOR
K900700 · Ppg Industries, Inc. · Apr 1990
CARDIOCAP(TM) CMX-104 MONITOR
K896190 · Datex Division Instrumentarium Corp. · Mar 1990